MOOD STABILIZERS Brian Gomoll, MD
MOOD STABILIZERS
Brian Gomoll, MD
GENERAL OVERVIEW
BIPOLAR DISORDER
BIPOLAR DISORDER
BIPOLAR DISORDER
THEORETICAL PATHWAYS IN MANIA
The American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioral Neurosciences, Fifth EditionEdited by Yudofsky SC, Hales RE. © 2008 American Psychiatric Publishing, Inc. All rights reserved. www.appi.org
7
FIGURE 27–4. A proposed model of mood regulation: Different sets of brain regions are involved in different aspects of mood experience and modulation.
One example of a neural network model for depression is presented in Figure 27–4. In this model, the network is potentially modulated by dysfunction (or by treatment) at “critical nodes” that produce effects elsewhere in the network.
Numerous interconnections exist among these different regions, and the system is recognized to be dynamic and potentially modulated at any critical node. Different treatments for mood disorder syndromes may act primarily at different nodes within the system, with therapeutic downstream effects. PF9/46=dorsolateral prefrontal cortex; PM6=premotor area; Par40=dorsal parietal; hc=hippocampus; aCg24b=Brodmann area 24b/dorsal-perigenual anterior cingulate cortex; mCg24c=Brodmann area 24c/dorsal anterior cingulate cortex; pCg=posterior cingulate gyrus; mF9/10=medial frontal cortex; rCg24a=Brodmann area 24a/perigenual-subgenual cingulate cortex; oF11=orbitofrontal cortex; cd-vst=ventral caudate–ventral striatum; thal=thalamus; amg=amygdala; mb-sn=midbrain–subthalamic nuclei; sgCg25=Brodmann area 25/subgenual cingulate cortex; a-ins=anterior insula, hth=hypothalamus, bstem=brain stem; CBT=cognitive-behavioral therapy; DBS=deep brain stimulation of Brodmann area 25; MEDS=antidepressant medications.
MANIA – NOT JUST BIPOLAR DISORDER
MOOD STABILIZERS - USES
Bipolar Disorders Bipolar I Bipolar II Cyclothymic Disorder Other bipolar
Depressive Disorders Adjunctive Treatment
Psychotic Disorders (Antipsychotics) Adjunctive antiepileptics (controversial) Schizoaffective
Controversial, depends on agent
Subclinical / Comorbid Mood Symptoms Personality Disorders
Aggression / Impulsivity
Suicidality
Other Indications Seizures (antiepileptics) Headaches (antiepileptics, lithium) Tremor (topiramate)
SINGLE CLASS?
Can be considered four treatment indications: Acute mania Acute depression Maintenance / prevention of mania Maintenance / prevention of
depression
Multiple pathways and effects, different set of non-bipolar uses, different pharmacology
LITHIUM
LITHIUM – THE FIRST MOOD STABILIZER
Inorganic ion
Unknown mechanism of action Blockade of inositol triphosphate
formation, accumulation of intracellular inositol phosphate
Reduction of hormone-induced cAMP (though not pronounced in brain)
Proven to have prophylactic effect in re: recurrence of episodes
Less efficacious in treatment of acute bipolar depression
LITHIUM - BENEFITS
Strong evidence with multiple trials
Anti-suicidal
Avoids some side effects of anti-epileptic and antipsychotic medications Though has it own side effects
Adjunct for treatment-resistant depression
LITHIUM - MONITORING
Long half-life and relatively narrow therapeutic window
Requires monitoring of blood level, thyroid function, renal function
Patient needs to maintain relatively stable and adequate fluid and sodium intake
LITHIUM – ADVERSE EFFECTS
Nausea, vomiting, diarrhea
Neurologic Tremor Cognitive dulling
Renal Inhibition of ADH action Na+ retention Renal tubular damage may occur with
prolonged use
Thyroid enlargement and hypothyroidism
Weight gain
Cardiovascular EKG Changes (T-wave suppression,
irregular rhythm, aggravates sick sinus) Edema
Dermatologic Worsens acne, psoriasis Maculopapular and follicular rash
Teratogenic Ebstein’s anomaly*
Leukocytosis
LITHIUM - TOXICITY
Neurologic Tremor Cogwheeling Drowsiness Confusion Disorientation Fasciculations Ataxia Extrapyramidal side effects Seizure
Risk Factors: Fever Major Surgery Renal failure Low food/salt intake Age Acute overdose
Medications
LITHIUM & PREGNANCY
Increased risk of fetal cardiac abnormalities Ebstein’s anomaly 1:20000 live births 1:1000 with lithium
Transient CNS depression in newborn
Requires careful thyroid monitoring, lithium level changes
No long-term behavioral effects
No consensus, but usually not recommended in breastfeeding
LITHIUM – DRUG INTERACTIONS
NSAIDS Ibuprofen, indomethacin, naproxen, cox-
2 inhibitors
Thiazide diuretics Hydrochlorothiazide (HCTZ)
Nonthiazide diuretics
Antibiotics Tetracyclines
Calcium antagonists Verapamil
Xanthines Caffeine Theophylline
Osmotic diuretics Mannitol
Carbonic anhydrase inhibitors Acetazolamide
LITHIUM – WHY USE?
Best efficacy for mania, maintenance treatment
One of two medications known to have anti-suicidal properties The other being clozapine
Adjunctive treatment of depression
Though has multiple side effects, many patients tolerate it well and may prefer lithium’s potential side effects to others
Pregnancy (with risk/benefit)
ANTI-EPILEPTICS
ANTI-EPILEPTICS
Valproic Acid / Divalproex Depakene, Depakote
Carbamazepine Tegretol
Lamotrigine Lamictal
Oxcarbazepine Trileptal
ANTI-EPILEPTICS:
Valproic Acid First drug since lithium to be approved Better than lithium for mixed states or rapid-
cycling? (Controversial) Beneficial in manic phase, not as beneficial
in depression
Carbamazepine Comparable to valproic acid, often used in
treatment-resistant
Lamotrigine Not useful for acute therapy, but has efficacy
in bipolar depression and maintenance
ANTI-EPILEPTICS: ADVERSE EFFECTS
ANTI-EPILEPTICS: ADVERSE EFFECTS
ANTI-EPILEPTICS: NEWER AGENTS?
Mostly unsuccessful use of other anti-epileptics
Gabapentin (Neurontin) had some hope but has not shown efficacy Though can be helpful for anxiety
Topiramate (Topamax) use also unclear Helps with weight loss
Oxcarbazepine (Trileptal) Some good evidence (along line of
carbamazepine)
BENZODIAZEPINES
Use in acute mania and psychosis in context of bipolar disorder
Lorazepam (Ativan) PO/IM
Clonazepam (Klonopin) Longer acting
Increased abuse potential in bipolar patients with long-term use
ANTIPSYCHOTICS
ANTIPSYCHOTICS
First generation / Typical Not used in maintenance, may be used
in acute psychosis/mania Haloperidol (Haldol) PO/IM
Second generation / Atypical Increasing use as monotherapy /
combination therapy in bipolar patients Unclear mechanism in bipolar
Due to greater 5-HT2 antagonism? Subcortical DA dysfunction?
ANTIPSYCHOTICS - EXAMPLES
Risperidone (Risperdal) More “typical” than most atypicals Comes in PO, dissolving tab, long-acting
IM
Olanzapine (Zyprexa) Combination with SSRI (fluoxetine,
Symbyax) approved for bipolar depression Has long-acting IM and short-acting IM Long-acting IM difficult to give
Aripiprazole (Abilify) Has long-acting IM
Quetiapine (Seroquel) Sedation may help with sleep
Ziprasidone (Geodon) Somewhat more weight-neutral
Clozapine (Clozaril) Anti-suicidal Multiple side effects Requires blood monitoring Most efficacious antipsychotic
ANTIPSYCHOTICS – ADVERSE EFFECTS
EPS
Increased risk of tardive dyskinesia in mood disorder patients
Neuroleptic Malignant Syndrome
Hyperprolactinemia (typicals, risperidone)
Sedation (worse in clozapine, olanzapine, quetiapine)
Akathisia
Weight gain / Metabolic Syndrome
Seizures (at increased doses)
Anticholinergic effects
Decreased sexual drive and functioning
Leukopenia / Agranulocytosis
Cognitive Effects
OTHER TREATMENTS
Electroconvulsive Therapy Extremely good efficacy for mania,
melancholic depression
Transcranial Magnetic Stimulation Being researched for mania
Psychotherapy Different protocols with various evidence Adjunct to medications in vast majority
Lifestyle Changes Maintain consistent, good sleep schedule Avoid stimulants and other triggers
OVERVIEW – MECHANISMS?
BOOKS REFERENCED
“Essential Psychopharmacology” by Stephen M. Stahl
“Principles and Practice of Psychopharmacotherapy” by Janicek et al
“The American Psychiatric Publishing Textbook of Neuropsychiatry & Behavioral Neuroscience” by Yudofsky et al
“Massachusetts General Hospital Handbook of General Hospital Psychiatry” by Stein el al
“Marbles: Mania, Depression, Michelangelo & Me” by Ellen Forney
Also recommended: “Psychiatric Tales” by Daryl Cunningham